title: Aztreonam plus cefazolin: a double beta-lactam combination as empirical therapy in febrile cancer patients with or without granulocytopenia.
authors.affiliation: Infectious Diseases Institute, University of Perugia, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Menichetti
authors.forename: G
authors.initials: G
authors.lastname: Bucaneve
authors.forename: L
authors.initials: L
authors.lastname: Patoia
authors.forename: R
authors.initials: R
authors.lastname: Guerciolini
authors.forename: V
authors.initials: V
authors.lastname: Minotti
authors.forename: S
authors.initials: S
authors.lastname: Pauluzzi
authors.forename: A
authors.initials: A
authors.lastname: Del Favero
mesh_terms: D000380:Agranulocytosis / Q000150:complications*; D001398:Aztreonam / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy* / Q000209:etiology; D002437:Cefazolin / Q000627:therapeutic use*; D002443:Ceftriaxone / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D005260:Female; D005334:Fever / Q000188:drug therapy* / Q000209:etiology; D006090:Gram-Negative Bacteria / Q000302:isolation & purification; D006094:Gram-Positive Bacteria / Q000302:isolation & purification; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000150:complications*
chemical_list: D002443:Ceftriaxone; D001398:Aztreonam; D002437:Cefazolin